BioCentury
ARTICLE | Company News

Biotie, Lundbeck, Stada deal

January 7, 2008 8:00 AM UTC

Stada's Britannia Pharmaceuticals Ltd. subsidiary returned to BioTie exclusive U.K. and Irish rights to nalmefene to treat substance abuse and impulse control disorders. Britannia received the rights...